

#57863
Mentioned in 1 episodes
A Crack in Creation
Gene Editing and the Unthinkable Power to Control Evolution
Book • 2017
This book is a blend of scientific discovery and personal reflection, where Doudna explores the consequences of her work on CRISPR.
It provides accessible technical descriptions, key events, and ethical and social challenges associated with gene editing.
Doudna delves into the broader implications of CRISPR, including its potential to control evolution and the ethical dilemmas it poses, particularly in the context of human germline editing.
It provides accessible technical descriptions, key events, and ethical and social challenges associated with gene editing.
Doudna delves into the broader implications of CRISPR, including its potential to control evolution and the ethical dilemmas it poses, particularly in the context of human germline editing.
Mentioned by
Mentioned in 1 episodes
Mentioned by ![undefined]()

when discussing 

's childhood and influences.

Lawrence Krauss


Jennifer Doudna

13 snips
Jennifer Doudna: Scientist and World Changer
Mentioned as the title of Jennifer Doudna's Nobel book.

C2GTalk: How does society view solar radiation modification experiments? with Sheila Jasanoff
Mentioned in the context of discussing gene editing technology and its potential risks.

Fri. 05/03 - Facebook Coin Is Coming For Credit Cards
Mentioned by 

when discussing the prevalence of viruses in the ocean and their impact on bacteria.


David Friedberg

E1 All-In with Chamath Palihapitiya & Jason Calacanis: US Response to COVID-19 & Impact on Startups, Venture Capital & Public Markets with David Friedberg
Mentioned by 

as one of his favorite books.


Clay Wilkes

20VC: Why The Unbundling of Fintech Will Continue, How VCs Are Propping Up The Neo-Banking Industry & Why We Need A New Framework To Value Businesses Today with Clay Wilkes, Founder & CEO @ Galileo
Mentioned by 

while discussing the prevalence of viruses in the ocean and their impact on bacteria.


David Friedberg

E1: US Response to COVID-19 & Impact on Startups, Venture Capital & Public Markets with David Friedberg